Hims & Hers Health开始销售诺和诺德的Wegovy、Ozempic

2026-03-27 00:44

Hims & Hers Health (HIMS) said that it has begun selling Novo Nordisk (NVO) GLP-1 medicines Wegovy (semaglutide) and Ozempic (semaglutide), which are indicated for weight loss and type 2 diabetes.
All injectable strengths of Wegovy and Ozempic are available, as well as the Wegovy pill. The Wegovy HD injection, with a 7.2 mg dosage strength, will be available next month.
Hims & Hers is also starting a new membership for weight loss that offers support services, 24/7 access to providers, personalized nutrition guidance, and clinical check-ins. The membership cost begins at $39 for the first month and $149 thereafter. The fee doesn't include the cost of the medicine. The Wegovy injection starts at $199 a month, while the pill begins at $149. Ozempic starts at $199 a month.
Earlier in March, Hims & Hers ended a dispute with Novo Nordisk as the former was trying to sell cheaper compounded versions of semaglutide. Under an agreement, Hims & Hers can only make compounded versions under very limited circumstances.

More on Hims & Hers Health